Spectrascience New Stock Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Spectrascience New are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Spectrascience New has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Spectrascience New is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 1:100 | Last Split Date 2003-11-18 |
Spectrascience |
Spectrascience New Relative Risk vs. Return Landscape
If you would invest 0.00 in Spectrascience New on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Spectrascience New or generate 0.0% return on investment over 90 days. Spectrascience New is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Spectrascience, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Spectrascience New Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spectrascience New's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Spectrascience New, and traders can use it to determine the average amount a Spectrascience New's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SCIE |
Based on monthly moving average Spectrascience New is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spectrascience New by adding Spectrascience New to a well-diversified portfolio.
Spectrascience New Fundamentals Growth
Spectrascience Stock prices reflect investors' perceptions of the future prospects and financial health of Spectrascience New, and Spectrascience New fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spectrascience Stock performance.
| Return On Asset | -0.92 | ||||
| Current Valuation | 492.38 K | ||||
| Shares Outstanding | 4.92 B | ||||
| Price To Earning | (0.04) X | ||||
| Price To Sales | 73.07 X | ||||
| Revenue | 5.15 K | ||||
| Gross Profit | (194.25 K) | ||||
| EBITDA | (1.99 M) | ||||
| Net Income | (4.47 M) | ||||
| Cash And Equivalents | 27.88 K | ||||
| Total Debt | 6.38 M | ||||
| Current Ratio | 0.02 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (1.51 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 492.38 K | ||||
| Total Asset | 1.39 M | ||||
| Retained Earnings | (53.97 M) | ||||
| Working Capital | (10.5 M) | ||||
| Current Asset | 479 K | ||||
| Current Liabilities | 10.98 M | ||||
About Spectrascience New Performance
By analyzing Spectrascience New's fundamental ratios, stakeholders can gain valuable insights into Spectrascience New's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spectrascience New has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spectrascience New has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 149.24 | 141.78 | |
| Return On Tangible Assets | (14.20) | (13.49) | |
| Return On Capital Employed | 0.23 | 0.25 | |
| Return On Assets | (3.71) | (3.52) | |
| Return On Equity | 0.38 | 0.40 |
Things to note about Spectrascience New performance evaluation
Checking the ongoing alerts about Spectrascience New for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spectrascience New help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spectrascience New generated a negative expected return over the last 90 days | |
| Spectrascience New has some characteristics of a very speculative penny stock | |
| Spectrascience New has high likelihood to experience some financial distress in the next 2 years | |
| Spectrascience New currently holds 6.38 M in liabilities. Spectrascience New has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spectrascience New's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (194.25 K). | |
| Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations. | |
| Spectrascience New has a frail financial position based on the latest SEC disclosures |
- Analyzing Spectrascience New's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spectrascience New's stock is overvalued or undervalued compared to its peers.
- Examining Spectrascience New's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spectrascience New's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spectrascience New's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spectrascience New's stock. These opinions can provide insight into Spectrascience New's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Spectrascience Stock analysis
When running Spectrascience New's price analysis, check to measure Spectrascience New's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectrascience New is operating at the current time. Most of Spectrascience New's value examination focuses on studying past and present price action to predict the probability of Spectrascience New's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectrascience New's price. Additionally, you may evaluate how the addition of Spectrascience New to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |